 Connection
Joshua Petit to Brachytherapy
This is a "connection" page, showing publications Joshua Petit has written about Brachytherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.523 |
|
|
|
-
Petit JH, Gluck C, Kiger WS, Henry DL, Karasiewicz C, Talcott J, Berg S, Holupka E, Kaplan I. Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. Urol Oncol. 2008 Jul-Aug; 26(4):372-7.
Score: 0.248
-
Petit JH, Gluck C, Kiger WS, Laury Henry D, Karasiewicz C, Talcott JA, Berg S, Holupka EJ, Kaplan ID. Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume. Brachytherapy. 2007 Oct-Dec; 6(4):267-71.
Score: 0.245
-
Devlin PM, Gaspar LE, Buzurovic I, Demanes DJ, Kasper ME, Nag S, Ouhib Z, Petit JH, Rosenthal SA, Small W, Wallner PE, Hartford AC. American College of Radiology-American Brachytherapy Society practice parameter for electronically generated low-energy radiation sources. Brachytherapy. 2017 Nov - Dec; 16(6):1083-1090.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|